Cytokinetics to Present 3 MAPLE-HCM Late-Breaking at AHA 2025
Cytokinetics (Nasdaq: CYTK) announced multiple presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions on…
Genetic study reveals unique mutations in Chinese patients with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM), a common genetic heart disorder, is often caused by mutations in sarcomere-related genes. While extensively…